Sort
48,018 grants matching “immunotherapy”
Nanoconjugate delivery of proliferation and checkpoint inhibitors to treat glial tumors
$541,408Julia Y Ljubimova · Cedars-Sinai Medical Center · R01 · FY2019 · CA
Advancing RAS pathway targeted therapy in NF1-MPNST: effects of SHP2 and CDK4/6 inhibitors on the tumor and the tumor immune microenvironment
$541,365Christine Anne Pratilas · Johns Hopkins University · R01 · FY2024 · CA
TRAINING GRANT IN MOLECUCLAR IMAGING RESEARCH AND CANCER SYSTEMS ANALYSIS
$541,273Ralph Weissleder · Massachusetts General Hospital · T32 · FY2022 · CA
Novel Targets for Vaccine Therapy
$541,259Jeffrey Schlom · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Clinical Trials and Translation
$541,237Julie R Park · Children'S Hospital Of Los Angeles · P01 · FY2019 · CA
Novel Computation Methods for the Analysis of Cell-Free DNA Sequence Data
$541,133Xianghong Jasmine Zhou · University Of California Los Angeles · R01 · FY2022 · CA
City of Hope Clinical Oncology Career Research Development Program
$541,052Joanne E. Mortimer · Beckman Research Institute/City Of Hope · K12 · FY2013 · CA
Utilizing MEK Inhibition to Sensitize Microsatellite Stable Colorectal Cancer to Immune Checkpoint Therapy
$541,043Christopher Hanyoung Lieu · University Of Colorado Denver · R01 · FY2019 · CA
Dissecting Pediatric Brain Tumor Microenvironment to Improve Treatment
$541,032Rakesh K. Jain · Massachusetts General Hospital · R35 · FY2015 · CA
Clinical Protocol and Data Management
$540,954Shaalan Beg · Ut Southwestern Medical Center · P30 · FY2021 · CA
Clinical Protocol and Data Management
$540,954Assal Shoushtari Rahimi · Ut Southwestern Medical Center · P30 · FY2024 · CA
Clinical Protocol and Data Management
$540,954Shaalan Beg · Ut Southwestern Medical Center · P30 · FY2022 · CA
Clinical Protocol and Data Management
$540,954Assal Shoushtari Rahimi · Ut Southwestern Medical Center · P30 · FY2023 · CA
Program stem-like CD8 T cells to enhance antiviral immunity against chronic viral infection
$540,929Tuoqi Wu · Ut Southwestern Medical Center · R01 · FY2023 · AI
ONCOLYTIC IMMUNOTHERAPY FOR DIFFUSE INTRINSIC PONTINE GLIOMAS
$540,881Universidad De Navarra · · FY2017 · Department of the Army
Impact of Foreign Bodies on Infection Susceptibility, Disease and Mucosal Remodeling of the Urinary Tract
$540,879Scott J Hultgren · Washington University · R01 · FY2025 · DK
Flexible NLP toolkit for automatic curation of outcomes for breast cancer patients
$540,872Imon Banerjee · Mayo Clinic Arizona · U01 · FY2023 · CA
Interrogating the response of the tumor microenvironment to combination immunotherapy using a microfluidic platform
$540,860Albert Folch · University Of Washington · R01 · FY2021 · CA
Phase II Trial of HOKT3gamma 1 (ALA-ALA) in Type 1 Diabetes
$540,834Kevan C Herold · Yale University · R01 · FY2007 · DK
Dual action immunostimulatory nanoparticles for treatment of aggressive cancers
$540,823Efstathios Karathanasis · Case Western Reserve University · R01 · FY2025 · CA
Pan-Cancer characterization of 3âUTR somatic mutations controlling tumor immune evasion
$540,818Ioannis Vlachos · Beth Israel Deaconess Medical Center · R01 · FY2024 · CA
Novel combined immunotherapeutic strategies for glioma: using pet dogs as a large animal spontaneous model
$540,797Grace Elizabeth Pluhar · University Of Minnesota · U01 · FY2020 · CA
Novel combined immunotherapeutic strategies for glioma: using pet dogs as a large animal spontaneous model
$540,797Grace Elizabeth Pluhar · University Of Minnesota · U01 · FY2021 · CA
Defining post-transcriptional mechanisms that control CD8 T cell longevity, proliferation and differentiation
$540,675Leonid Pobezinskiy · University Of Massachusetts Amherst · R01 · FY2022 · AI
Defining post-transcriptional mechanisms that control CD8 T cell longevity, proliferation and differentiation
$540,675Leonid Pobezinskiy · University Of Massachusetts Amherst · R01 · FY2023 · AI